Please login to the form below

Not currently logged in

Lucid Group promotes Clare Reynolds to newly created role

Reynolds initially joined Lucid in 2009 as business unit director

Lucid Group has promoted Clare Reynolds (pictured above) to director of business development and commercial integration.

Reynolds initially joined Lucid in 2009 as business unit director – since then, she has progressed through the ranks at the medcomms company, most recently working as senior managing partner.

In a statement, Lucid said Reynolds had played a 'key role' in developing new and existing clients for the company, leading to the promotion.

In her new role, Reynolds will aim to enhance Lucid's ability to improve health outcomes and also build on the company's strategic partnerships.

She will also lead the introduction of new capabilities into Lucid's teams to attract new clients, companies and candidates.

"By firmly engaging with this intent through our client partnerships, we lead with improving patient outcomes and build our business in the process," commented Reynolds.

"This new role creates the opportunity to more tangibly align the way we approach our client partnerships with our vision, and to expand our capabilities in a way that brings incremental value to our clients and the healthcare communities within which we work," she added.

Prior to Lucid, Reynolds served as marketing director, HIV International for Gilead Sciences.

Article by
Lucy Parsons

29th April 2021

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...